- (1) Testing Methodologies: Methodologies used to screen for and confirm the administration of medications, drugs, and naturally occurring substances in racing horses shall be limited to the following: Immunoassay, Liquid Chromatography Mass Spectrometry (LCMS), Gas Chromatography Mass Spectrometry (GCMS), Clinical Refractometer, and/or Specific Gravity.
(2) Measurement Uncertainties: The Division hereby incorporates by reference the Division Laboratory Measurement Uncertainty Schedule containing the established levels. An electronic copy can be located at HYPERLINK "https://www.flrules.org/Gateway/reference.asp?No=Ref-13341" https://www.flrules.org/Gateway/reference.asp?No=Ref-13341, Effective Date: 07-13-2021.
- (a) All measurement uncertainties have been established at the maximum allowable concentration for those substances, analytes, and corresponding metabolites or markers contained within Rule 75-6.008, F.A.C., that undergo quantitative analysis, unless otherwise specified.
- (b) If a sample is diluted for testing, the measurement uncertainty is multiplied by the factor of dilution.
- (c) Measurements of uncertainty are not established for the testing of specimens in which the identification of a substance, analyte, or corresponding metabolite or marker at or above the lowest level of detection is sufficient to constitute a violation.
- (3) Screening Limit for Prohibited Substances in Racing Horses: Any and all findings above zero that are over the limit of detection, under any condition of use, for prohibited substances shall be considered a violation of Section 550.2415, F.S.
Rulemaking Authority 550.0251(3), (11), 550.2415(12) FS. Law Implemented 550.0251, 550.2415 FS. History–New 10-20-96, Amended 6-6-00, 6-6-04, 4-12-06, 6-26-11, 8-1-19, 8-4-21, Formerly 61D-6.007.